Navigation Links
Anthera Announces Fourth Quarter 2011 Financial Report and Conference Call
Date:2/9/2012

HAYWARD, Calif., Feb. 9, 2012 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company developing drugs to treat serious diseases associated with inflammation, will release its fourth quarter 2011 financial report before the market opens on Tuesday, February 21, 2012. Anthera will host a conference call at 1 pm Eastern Time in conjunction with the release. The Company will also provide an update for both the varespladib and blisibimod clinical programs. Conference Call Access:Date:

Tuesday, February 21, 2012Time:

1:00 pm Eastern Time

Domestic Dial-in:

(877) 312-8807International Dial-in:

(253) 237-1190Conference ID:

47038854

To access the 24-hour audio replay, U.S. and Canadian participants may dial (855) 859-2056; international participants may dial (404) 537-3406.  The conference ID for the replay is 47038854. The audio replay will be available until February 28, 2012. 

About Anthera PharmaceuticalsAnthera Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing products to treat serious diseases associated with inflammation, including cardiovascular and autoimmune diseases.  Anthera has three late stage clinical products: varespladib methyl (A-002), A-001 and blisibimod (A-623).  Varespladib methyl (A-002) and A-001 are designed to inhibit a novel enzyme target known as secretory phospholipase A2 (sPLA2).  Elevated levels of sPLA2 have been implicated in a variety of acute inflammatory conditions, including acute coronary syndrome and acute chest syndrome, as well as chronic diseases such as stable coronary artery disease.  Blisibimod targets elevated levels of B-lymphocyte stimulator (BAFF), which have been associated with a variety of B-Cell mediated autoimmune diseases, includi
'/>"/>

SOURCE Anthera Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Anthera Announces Completion of Enrollment and Dosing in Phase II Trial of A-002 for the Treatment of Cardiovascular Disease
2. Anthera Announces Positive Phase II Clinical Results From A-002 Cardiovascular Disease Trial
3. Antheras A-001 Receives Orphan Drug Status for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
4. Anthera Announces Preliminary Positive Results From Once-Daily A-002 Phase II Cardiovascular Trial
5. Anthera Enters Into Manufacturing Agreements for Varespladib in Preparation for Pivotal Phase III Trials
6. DSMB Supports Continuation of Anthera Phase II Impacts Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
7. Anthera Pharmaceuticals Advances Global Development Strategy for Varespladib in Patients With Acute Coronary Syndrome With the Initiation of FRANCIS Trial
8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
9. Following Encouraging Results Anthera to Continue IMPACTS Trial for the Prevention of Acute Chest Syndrome in Patients With Sickle Cell Disease
10. Antheras Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome
11. Anthera Pharmaceuticals Announces Agreement With the FDA on a SPA for Planned Phase 3 Varespladib A-002 Study; Daniel K. Spiegelman Joins Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)...   Gulf Coast Tattoo Removal is the first and ... Duality laser in Southern Mississippi . Gulf Coast ... and take back control of their skin. The clinic is located ... to Biloxi , Gulfport , ... being as prevalent as it is, I was surprised by the ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015 ... the addition of the "An Introduction to ... - November 2-3, 2015)" conference to their ... a comprehensive introduction to the regulations and requirements ... will be highly interactive, using real life examples ...
(Date:9/2/2015)... DUBLIN , Sept. 2, 2015  Research ... addition of the "An Introduction to the ... 2015)" conference to their offering. ... the European medical device legislation. It will explain ... involvement of Notified Bodies, how to choose one ...
Breaking Medicine Technology:Gulf Coast Tattoo Removal Delivers Unrivaled Tattoo Removal Results To Biloxi And Gulfport With Astanza Duality 2An Introduction to Medical Device Software: Regulations and Requirements Course - London, UK - November 2-3, 2015 2
(Date:9/2/2015)... ... 02, 2015 , ... Date and time: Oct. 3, 2015, 9 a.m. to ... Tomlinson Road, Bryn Athyn, Pa 19009 , Cost: $50 per person; includes lunch , ... Times best-selling author Sam Keen based on his new book which he co-authored with ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... of Things, announces its latest addition to its screen mirroring and extending product ... Splashtop Extended Wireless Display, which operates in local WIFI setting, the new Splashtop ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Michael Elliot Media ... feature a plus-size actress as the primary love interest in the film. The campaign ... and film, significantly affects how and what we think,” Michael Elliot, an award-winning screenwriter ...
(Date:9/2/2015)... , ... September 02, 2015 , ... Ericson is a ... Education Director for HCPro and Associate Director of Education for the Association for Clinical ... CDI and ICD-10 for CDI Boot Camps. She serves as a CDI subject matter ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... A recent ... prices over the past year and its negative impact on consumers. It was reported ... medication and 10% were paying as much as an extra $100 compared to last ...
Breaking Medicine News(10 mins):Health News:justCommunity, Inc. and Bryn Athyn Men’s Groups Present Workshop on Family Reconciliation 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 2Health News:Splashtop Launches Wired XDisplay, the Fastest Screen Sharing Solution for Extending and Mirroring Your Computer Screen to Mobile Devices 3Health News:Award-Winning Screenwriter Uses Crowdfunding Campaign to Change Hollywood’s Ideal of Beauty to Include PLUS-SIZE Women 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 2Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 3Health News:ezDI Names Noted CDI Educator Cheryl Ericson as Company’s Clinical Documentation Manager 4Health News:Watertree Health President Responds to Consumer Reports Survey on Rising Prescription Drug Prices 2
... Lancet investigated the efficacy of acupuncture compared with minimal ... of the knee.,Acupuncture is a commonly used procedure to ... ,By random allocation, patients with chronic osteoarthritis ... group consisting of 150 were allocated to the acupuncture ...
... the people’s body react to cholesterol increase depends on their ... of low-density lipoprotein (LDL) may affect twins in the same ... each other. Researchers of Department of Energy’s Lawrence Berkeley National ... of identical twins, where one of them always had a ...
... say that families can now hang on to their departed ... by a US genetic testing company. The service is being ... Orchid says the DNA information would be useful for medical, ... An individual's DNA can provide a wide range of information ...
... pregnancy depressions, health care// workers have tried to identify women ... and taken preventive measures to avoid the condition. However a ... who had reviewed 15 randomized control trials on 7,697 women ... depression but the treatment meted out to the pregnant women ...
... other than that can be perceived//. The primary similarities they ... them very different form each other. ,Researchers have reported ... of their epigenome. Epigenome is the modifications that happen in ... of the varied expressions of the gene’s DNA. Epigenome can ...
... trials support the enhanced bioavailability// of CoQ10 delivered into ... of CoQ10 products. ,Increasing its bioavailability, or ... food makers to use lower dosages, therefore saving on ... emulsifiers and solvents to trap water droplets in oil. ...
Cached Medicine News:
70 discs to investigate acquired color deficiency. Quantifies neutral zone characteristics of dyschromatopsia and evaluates the relative luminance....
... The NOW Hepatitis B test is a ... diagnosis of a Hepatitis B infection. This simple, ... for accurate treatment and improved patient outcomes. , ... is an in vitro immunodiagnostic test for the ...
... is the newest technology available in acrylic ... combines exceptional material and design properties to ... Biostability , Unique foldable hydrophobic acrylic material ... be biostable , High index of ...
Single Use Loading Units with Titanium Staples for use with Powered MULTIFIRE ENDO GIA™ 60 (15 mm Single Use Stapler with Titanium Staples)....
Medicine Products: